Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.
Rätze MAK, Koorman T, Sijnesael T, Bassey-Archibong B, van de Ven R, Enserink L, Visser D, Jaksani S, Viciano I, Bakker ERM, Richard F, Tutt A, O'Leary L, Fitzpatrick A, Roca-Cusachs P, van Diest PJ, Desmedt C, Daniel JM, Isacke CM, Derksen PWB. Rätze MAK, et al. Among authors: desmedt c. Oncogene. 2022 Jun;41(26):3507-3509. doi: 10.1038/s41388-022-02355-1. Oncogene. 2022. PMID: 35610485 Free PMC article. No abstract available.
ESR1 mutations in metastatic lobular breast cancer patients.
Desmedt C, Pingitore J, Rothé F, Marchio C, Clatot F, Rouas G, Richard F, Bertucci F, Mariani O, Galant C, Fribbens C, O'Leary B, van den Eynden G, Salgado R, Turner NC, Piccart M, Vincent-Salomon A, Pruneri G, Larsimont D, Sotiriou C. Desmedt C, et al. NPJ Breast Cancer. 2019 Feb 22;5:9. doi: 10.1038/s41523-019-0104-z. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 30820448 Free PMC article.
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
Christgen M, Kandt LD, Antonopoulos W, Bartels S, Van Bockstal MR, Bredt M, Brito MJ, Christgen H, Colpaert C, Cserni B, Cserni G, Daemmrich ME, Danebrock R, Dedeurwaerdere F, van Deurzen CH, Erber R, Fathke C, Feist H, Fiche M, Gonzalez CA, Ter Hoeve ND, Kooreman L, Krech T, Kristiansen G, Kulka J, Laenger F, Lafos M, Lehmann U, Martin-Martinez MD, Mueller S, Pelz E, Raap M, Ravarino A, Reineke-Plaass T, Schaumann N, Schelfhout AM, De Schepper M, Schlue J, Van de Vijver K, Waelput W, Wellmann A, Graeser M, Gluz O, Kuemmel S, Nitz U, Harbeck N, Desmedt C, Floris G, Derksen PW, van Diest PJ, Vincent-Salomon A, Kreipe H. Christgen M, et al. Among authors: desmedt c. J Pathol Clin Res. 2022 Mar;8(2):191-205. doi: 10.1002/cjp2.253. Epub 2021 Dec 10. J Pathol Clin Res. 2022. PMID: 34889530 Free PMC article.
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.
Rätze MAK, Koorman T, Sijnesael T, Bassey-Archibong B, van de Ven R, Enserink L, Visser D, Jaksani S, Viciano I, Bakker ERM, Richard F, Tutt A, O'Leary L, Fitzpatrick A, Roca-Cusachs P, van Diest PJ, Desmedt C, Daniel JM, Isacke CM, Derksen PWB. Rätze MAK, et al. Among authors: desmedt c. Oncogene. 2022 May;41(21):2932-2944. doi: 10.1038/s41388-022-02314-w. Epub 2022 Apr 18. Oncogene. 2022. PMID: 35437308 Free PMC article.
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
Van Baelen K, Geukens T, Maetens M, Tjan-Heijnen V, Lord CJ, Linn S, Bidard FC, Richard F, Yang WW, Steele RE, Pettitt SJ, Van Ongeval C, De Schepper M, Isnaldi E, Nevelsteen I, Smeets A, Punie K, Voorwerk L, Wildiers H, Floris G, Vincent-Salomon A, Derksen PWB, Neven P, Senkus E, Sawyer E, Kok M, Desmedt C. Van Baelen K, et al. Among authors: desmedt c. Ann Oncol. 2022 Aug;33(8):769-785. doi: 10.1016/j.annonc.2022.05.006. Epub 2022 May 21. Ann Oncol. 2022. PMID: 35605746 Free article. Review.
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer.
De Schepper M, Vincent-Salomon A, Christgen M, Van Baelen K, Richard F, Tsuda H, Kurozumi S, Brito MJ, Cserni G, Schnitt S, Larsimont D, Kulka J, Fernandez PL, Rodríguez-Martínez P, Olivar AA, Melendez C, Van Bockstal M, Kovacs A, Varga Z, Wesseling J, Bhargava R, Boström P, Franchet C, Zambuko B, Matute G, Mueller S, Berghian A, Rakha E, van Diest PJ, Oesterreich S, Derksen PWB, Floris G, Desmedt C. De Schepper M, et al. Among authors: desmedt c. Mod Pathol. 2022 Dec;35(12):1812-1820. doi: 10.1038/s41379-022-01135-2. Epub 2022 Aug 3. Mod Pathol. 2022. PMID: 35922548 Free PMC article.
Reporting on invasive lobular breast cancer in clinical trials: a systematic review.
Van Baelen K, Van Cauwenberge J, Maetens M, Beck G, Camden A, Chase MC, Fraser V, Freeney S, Hutcheson L, Levine JK, Lien T, Terveer R, Turner C, Senkus E, Jankowitz RC, Vandecaveye V, Floris G, Neven P, Wildiers H, Sawyer E, Vincent-Salomon A, Derksen PWB, Desmedt C. Van Baelen K, et al. Among authors: desmedt c. NPJ Breast Cancer. 2024 Mar 20;10(1):23. doi: 10.1038/s41523-024-00627-5. NPJ Breast Cancer. 2024. PMID: 38509112 Free PMC article. Review.
236 results